Adenosine receptor control of cognition in normal and disease
JF Chen - International review of neurobiology, 2014 - Elsevier
Adenosine and adenosine receptors (ARs) are increasingly recognized as important
therapeutic targets for controlling cognition under normal and disease conditions for its dual …
therapeutic targets for controlling cognition under normal and disease conditions for its dual …
The role of adenosine A2A receptors in Alzheimer's disease and tauopathies
A Launay, O Nebie, JV Shankara, T Lebouvier… - …, 2023 - Elsevier
Adenosine signals through four distinct G protein-coupled receptors that are located at
various synapses, cell types and brain areas. Through them, adenosine regulates …
various synapses, cell types and brain areas. Through them, adenosine regulates …
[PDF][PDF] Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
RN Takahashi, FA Pamplona, RD Prediger - Front Biosci, 2008 - academia.edu
Introduction 3. Basic aspects of adenosine as a neuromodulator relevant for cognitive
functions 4. Effects of adenosine receptor antagonists on cognitive deficits in aged rodents …
functions 4. Effects of adenosine receptor antagonists on cognitive deficits in aged rodents …
Adenosine A2A receptors in psychopharmacology: modulators of behavior, mood and cognition
HY Shen, JF Chen - Current neuropharmacology, 2009 - ingentaconnect.com
The adenosine A2A receptor (A2AR) is in the center of a neuromodulatory network affecting
a wide range of neuropsychiatric functions by interacting with and integrating several …
a wide range of neuropsychiatric functions by interacting with and integrating several …
The role of adenosine in Alzheimer's disease
A Rahman - Current neuropharmacology, 2009 - ingentaconnect.com
Alzheimer's disease (AD) is a neurodegenerative disorder of the central nervous system
manifested by cognitive and memory deterioration, a variety of neuropsychiatric symptoms …
manifested by cognitive and memory deterioration, a variety of neuropsychiatric symptoms …
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?
S Merighi, A Travagli, M Nigro, S Pasquini, M Cappello… - Biomolecules, 2023 - mdpi.com
Alzheimer's disease (AD) is the most prevalent kind of dementia with roughly 135 million
cases expected in the world by 2050. Unfortunately, current medications for the treatment of …
cases expected in the world by 2050. Unfortunately, current medications for the treatment of …
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation
This review summarizes recent developments that have contributed to understand how
adenosine receptors, particularly A2A receptors, modulate brain injury in various animal …
adenosine receptors, particularly A2A receptors, modulate brain injury in various animal …
[HTML][HTML] Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies
CJ Wei, W Li, JF Chen - Biochimica et biophysica acta (BBA) …, 2011 - Elsevier
Endogenous adenosine is a widely distributed upstream regulator of a broad spectrum of
neurotransmitters, receptors, and signaling pathways that converge to contribute to the …
neurotransmitters, receptors, and signaling pathways that converge to contribute to the …
Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs
The neuromodulator adenosine fulfills a unique role in the brain affecting glutamatergic
neurotransmission and dopaminergic signaling via activation of adenosine A1 and A2A …
neurotransmission and dopaminergic signaling via activation of adenosine A1 and A2A …
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia,
activated by the neuromodulator adenosine, which interact with dopamine D2 receptors …
activated by the neuromodulator adenosine, which interact with dopamine D2 receptors …